We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Bioanalysis
BioTechniques
Future Drug Discovery
Future Medicinal Chemistry
Future Science OA
International Journal of Pharmacokinetics
Pharmaceutical Patent Analyst
Therapeutic Delivery
Commentary

Arrow declarations: here to stay or a flash in the pan?

    Dominic Adair

    *Author for correspondence: Tel.: +44 020 7400 8000;

    E-mail Address: dominic.adair@bristows.com

    Bristows, 100 Victoria Embankment, London EC4Y 0DH

    Search for more papers by this author

    Published Online:8 Jun 2018https://doi.org/10.4155/ppa-2018-0009
    Free first page

    References

    • 1 Arrow Generics Ltd v Merck & Co, Inc, England & Wales High Court (Patents Court), 31 July 2007 EWHC 1900 (Pat) (2007).Google Scholar
    • 2 See for example, Actavis v Lilly, England and Wales Court of Appeal (Civil Division), 21 May 2013 EWCA Civ 517 and Eli Lilly v Genentech England & Wales High Court (Patents Court), 6 December 2017 EWHC 3104 (Pat) (2013).Google Scholar
    • 3 Gillette Safety Razor Co. v Anglo-American Trading Co., UK House of Lords, 3 September 1913 30 RPC 465 (1913).Crossref, Google Scholar
    • 4 Fujifilm Kyowa Kirin Biologics Co. Ltd v AbbVie Ltd, England and Wales Court of Appeal (Civil Division), 12 January 2017 EWCA Civ 1 (2017).Google Scholar
    • 5 Fujifilm Kyowa Biologics Co. Ltd v AbbVie Biotechnology Ltd, England & Wales High Court (Patents Court), 1 March 2016 EWHC 425 (Pat) (2016).Crossref, Google Scholar
    • 6 Fujifilm Kyowa Kirin Biologics Co. Ltd v AbbVie Biotechnology Ltd, England & Wales High Court (Patents Court), 8 September 2016 EWHC 2204 (Pat) (2016).Crossref, Google Scholar
    • 7 Fujifilm Kyowa Kirin Biologics Co. Ltd v AbbVie Biotechnology Ltd, England & Wales High Court (Patents Court), 29 December 2016 EWHC 3383 (Pat) (2016).Crossref, Google Scholar
    • 8 Fujifilm Kyowa Kirin Biologics Co. Ltd v AbbVie Biotechnology Ltd, England & Wales High Court (Patents Court), 3 March 2017 EWHC 395 (Pat) (2017).Google Scholar
    • 9 Generics (UK) Ltd t/a Mylan v Yeda Research & Development Company Ltd, England & Wales High Court (Patents Court), 26 October 2017 EWHC 2629 (Pat) (2017).Google Scholar
    • 10 GSK Group v Vectura Ltd, England & Wales High Court (Patents Court), 23 February 2018 EWHC 375 (Pat) (2018).Google Scholar
    • 11 Actavis UK Ltd v Eli Lilly and Company, UK Supreme Court, 12 July 2017 UKSC 48 (2017).Google Scholar